Stability and Structural Features of DNA Intercalation with Ethidium Bromide, Acridine Orange and Methylene Blue
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Agarose Gel Electrophoresis
Laboratory for Environmental Pathogen Research Department of Environmental Sciences University of Toledo Agarose gel electrophoresis Background information Agarose gel electrophoresis of DNA is used to determine the presence and distinguish the type of nucleic acids obtained after extraction and to analyze restriction digestion products. Desired DNA fragments can be physically isolated for various purposes such as sequencing, probe preparation, or for cloning fragments into other vectors. Both agarose and polyacrylamide gels are used for DNA analysis. Agarose gels are usually run to size larger fragments (greater than 200 bp) and polyacrylamide gels are run to size fragments less than 200 bp. Typically agarose gels are used for most purposes and polyacrylamide gels are used when small fragments, such as digests of 16S rRNA genes, are being distinguished. There are also specialty agaroses made by FMC (e.g., Metaphor) for separating small fragments. Regular agarose gels may range in concentration from 0.6 to 3.0%. Pouring gels at less or greater than these percentages presents handling problems (e.g., 0.4% agarose for genomic DNA partial digests requires a layer of supporting 0.8% gel). For normal samples make agarose gels at 0.7%. The chart below illustrates the optimal concentrations for fragment size separation. The values listed are approximate and can vary depending on the reference that is used. If you do not know your fragment sizes then the best approach is to start with a 0.7% gel and change subsequently if the desired separation is not achieved. Nucleic acids must be stained prior to visualization. Most laboratories use ethidium bromide but other stains (e.g., SYBR green, GelStar) are available. -
Alzheimer's Disease, a Decade of Treatment: What Have We Learned?
A Critical Look at Medication Dementia: Alzheimer’s Disease Management Issues in Alzheimer’s Disease R.Ron Finley, B.S. Pharm., R.Ph,CGP Lecturer (Emeritus) and Assistant Clinical Professor, UCSF School of Pharmacy Clinical Pharmacist, UCSF Memory and Aging Center- Alzheimer’s Research Center Educational Objectives Disclosures 1. Define the role for cholinesterase inhibitors in the management of Alzheimer’s disease, Lewy Body dementia, Frontal Temporal Lobe dementia. Pfizer Speakers Bureau 2. Name three common side effects of atypical antipsychotic Forest Speakers Bureau drugs. Novartis Speakers Bureau 3. Construct a pharmacological treatment plan for a 77-year-old Rx Consultant Associate Editor patient diagnosed with Alzheimer’s disease and hallucinations. WindChime Consultant 4. Describe the role for antipsychotic, antidepressant, mood HGA HealthCare Consultant stabilizers and benzodiazepines in the management of psychiatric behavior problems related to Alzheimer’s disease. Elder Care Specialist Consultant 5. Cite three potential drug or disease interactions with cholinesterase inhibitors. The Many Faces of Dementia Risk Factors Linked to AD Alzheimer’s Disease Over 65 years of age and increases Vascular: Multi-infarct with age FrontalTemporal Lobe dementia ( FTD) and female Pick’s disease Head injury Lewy Body Dementia Progressive Supranuclear Palsy Factors associated with DM, HTN, CVD Corticobasal Degeneration Genetic: family history, specific Primary Progressive Aphasia chromosome mutations Huntington’s disease -
Gelred® and Gelgreen® Safety Report
Safety Report for GelRed® and GelGreen® A summary of mutagenicity and environmental safety test results from three independent laboratories for the nucleic acid gel stains GelRed® and GelGreen® www.biotium.com General Inquiries: [email protected] Technical Support: [email protected] Phone: 800-304-5357 Conclusion Overview GelRed® and GelGreen® are a new generation of nucleic acid gel stains. Ethidium bromide (EB) has been the stain of choice for nucleic acid gel They possess novel chemical features designed to minimize the chance for staining for decades. The dye is inexpensive, sufficiently sensitive and very the dyes to interact with nucleic acids in living cells. Test results confirm that stable. However, EB is also a known powerful mutagen. It poses a major the dyes do not penetrate latex gloves or cell membranes. health hazard to the user, and efforts in decontamination and waste disposal ultimately make the dye expensive to use. To overcome the toxicity problem In the AMES test, GelRed® and GelGreen® are noncytotoxic and of EB, scientists at Biotium developed GelRed® and GelGreen® nucleic acid nonmutagenic at concentrations well above the working concentrations gel stains as superior alternatives. Extensive tests demonstrate that both used in gel staining. The highest dye concentrations shown to be non-toxic dyes have significantly improved safety profiles over EB. and non-mutagenic in the Ames test for GelRed® and GelGreen® dyes are 18.5-times higher than the 1X working concentration used for gel casting, and 6-times higher than the 3X working concentration used for gel staining. This Dye Design Principle is in contrast to SYBR® Safe, which has been reported to show mutagenicity At the very beginning of GelRed® and GelGreen® development, we made a in several strains in the presence of S9 mix (1). -
Synthetic Drugs
Comprehensive and Confident Identification of Narcotics, Steroids and Pharmaceuticals in Urine David E. Alonso1, Petra Gerhards2, Charles Lyle1 and Joe Binkley1 | 1LECO Corporation, St. Joseph, MI; 2LECO European LSCA Centre, Moenchengladbach, Germany Introduction Experimental Sample A (Traditional Drugs) Sample B (Synthetic Drugs) Monitoring of patients in hospitals and clinics has traditionally relied on Samples Representative Compounds Representative Compounds targeted methods of analysis. These screening methods are not Peak # Name Formula R.T. (s) Area Similarity Mass Delta (mDa) MA (ppm) 1 Creatinine ME C5H9N3O 210 1326229 800 -0.05 -0.43 • Obtained from a collaborating European hospital 3.5e6 3.0e6 Peak # Name Formula R.T. (s) Area Similarity 2 o-Ethynylaniline C8H7N 219 167436 893 0.07 0.63 1 Indole C8H7N 213 2744171 917 comprehensive and result in an incomplete picture of a patient’s 3 2-Methoxy-4-vinylphenol C H O 223 65764 805 0.11 0.73 52 patient monitoring samples 9 10 2 2 Creatinine ME C5H9N3O 216 613318 651 • 2.5e6 4 Nicotine C10H14N2 234 3249121 898 -0.21 -1.29 3 Pyridine, 2-(1-methyl-2-pyrrolidinyl)- C10H14N2 230 24869771 899 activities. Gas chromatography high resolution time-of-flight mass 3.0e6 5 Hordenin C10H15NO 274 949734 775 -0.14 -0.84 4 Parabanic acid, 1-methyl- C4H4N2O3 233 434278 764 Sample preparation 5 Cotinine C10H12N2O 336 27810908 918 • 6 Methylecgonine C10H17NO3 276 104640 835 -0.22 -1.1 spectrometry (GC-HRT) provides a fast and convenient method for 2.0e6 5 6 Caffeine C8H10N4O2 371 3753598 797 2.5e6 7 4-(3-Pyridyl-tetrahydrofuran-2-one C9H9NO2 313 93817 849 -0.11 -0.68 3,4 7 1-methyl-7H-xanthine C6H6N4O2 437 4868196 850 analysis of urine samples. -
Supplementary Data for Publication
Electronic Supplementary Material (ESI) for Physical Chemistry Chemical Physics. This journal is © the Owner Societies 2016 Supplementary Data for Publication Synthesis of Eucalyptus/Tea Tree Oil Absorbed Biphasic Calcium phosphate-PVDF Polymer Nanocomposite Films: A Surface Active Antimicrobial System for Biomedical Application Biswajoy Bagchi1,δ, Somtirtha Banerjee1, Arpan Kool1, Pradip Thakur1,2, Suman Bhandary3, Nur Amin Hoque1 , Sukhen Das1+* 1Physics Department, Jadavpur University, Kolkata-700032, India. 2Department of Physics, Netaji Nagar College for Women, Kolkata-700092, India. 3Division of Molecular Medicine, Bose Institute, Kolkata-700054, India. +Present Address: Department of Physics, Indian Institute of Engineering Science and Technology, Shibpur, Howrah, West Bengal-711103, India. §Present Address: Fuel Cell and Battery Division, Central Glass and Ceramic Research Institute, Kolkata-700032, India. *Corresponding author’s email id: [email protected] Contact: +919433091337 Antimicrobial activity of EU and TTO treated films on E .coli and S. aureus by acridine orange/ethidium bromide (AO/EB) dual staining Live/dead cell characterization of EU/TTO film treated bacterial cultures was also done to visualize the viability under fluorescence microscope (). The treated culture suspensions after 12 and 24 hours of incubation were collected by centrifugation (5000 rpm, 20 mins). The cell pellets were resuspended in PBS. The staining solution was prepared by mixing equal parts of acridine orange (5mg/mL) and ethidium bromide (3mg/mL) in ethanol. 20μL of the staining solution is then mixed with 10μL of the resuspended solution and incubated for 15 minutes at 37°C. 10μL of this solution was then placed on a glass slide and covered with cover slip to observe under fluorescence microscope. -
Ethidium Bromide Alternatives Assessment August 2009 (Revised: August 2011)
MIT EHS Office Green Chemistry/Pollution Prevention Program Ethidium Bromide Alternatives Assessment August 2009 (revised: August 2011) Product Nucleic acids Visual Gel base and Sensitivity Stability or Types of visual Mutagenicity, Disposal Unit price, visualized and range, nm application (ug/mL) or Storage equipment Acute dose & cost method as (i.e., precast lowest Limits (gel Toxicity and per gel absorb/emit or post-gel) dilution documentation) Aquatic (abs/em) reported Toxicity Ethidium dsDNA 290 nm agarose 0.2ng-0.5ng May be UV Mutagenic with Managed Approx. $30 Bromide 1 ssDNA 605 nm stored at Transilluminator S9 activation as for 10mL of RNA acrylamide room of Salmonella hazardous 10mg/mL temperature; Polaroid 667 TA98 and waste solution; use PCR indefinite black & white TA1537 0.5µg/mL for storage strains agarose gel; yields 5,000 LD 50 , rat (oral): 40-mL gels, 1503 mg/kg $0.006/gel. (slightly toxic) Aquatic toxicity : LC 50 not available, MSDS indicates “may cause long- term adverse effects on aquatic environment” SYBR Safe 2 dsDNA 280/502 nm agarose Comparable Keep away UV Weakly Approved $53.75 for ssDNA 530 nm to ethidium from heat Transilluminator mutagenic with by MWRA 10,000X acrylamide bromide and light; S9 activation for drain SYBR Safe stable for blue (vis) light of Salmonella disposal, in DMSO, pre-cast approx. 6 transilluminator TA98 and May 2005 400µL; 4µL months (SafeImager™ TA1537 for 40 mL post-gel when stored recommended) strains gel = at room $0.5375 per temperature. laser scanner LD 50 , rat -
SYBR Safe Case Study
Replacing Ethidium Bromide in an Undergraduate Laboratory: SYBR Safe® Case Study March 2006 What is Ethidium Bromide and Why is it Used? Ethidium bromide (CAS #1239-45-8), or C21H20BrN3, is used in a number of laboratories, including those at MIT, for identifying DNA bands in samples that are loaded onto agarose gels. Ethidium bromide, commonly referred to as EtBr, binds to DNA. When placed under ultraviolet light, the EtBr-stained DNA bands fluoresce, allowing for the identification and visualization of nucleic acid bands. Ethidium bromide is considered an effective and relatively inexpensive technique for visualizing nucleic acid bands. Drawbacks of Ethidium Bromide Though effective and relatively inexpensive, ethidium bromide does have the following drawbacks for those handling the material in the lab: • it can be absorbed through the skin, irritating the eyes, mouth, and upper respiratory tract; • because of its tendency to intercalate in DNA bands, ethidium bromide is a powerful mutagen; • if handled indiscriminately in the lab, ethidium bromide can easily contaminate a large work area. When lab spaces are prepared for a move or for renovation, the space must be decontaminated of chemical, biological and radiological hazards. Because individual laboratories bear most, if not all, of the cost of decontaminating a lab, widespread ethidium bromide contamination may unnecessarily increase either the time or cost of lab preparation for moves or renovations; and • techniques for managing ethidium bromide waste are expensive - from a materials perspective, labor perspective, or both - or they beget more waste. Management of Ethidium Bromide Waste The United States Environmental Protection Agency (EPA) does not currently regulate ethidium bromide as a hazardous waste. -
THE POSSIBLE ROLE of LEUKOCYTE-GENERATED Reactrve INTERMEDIATES in the DRUG-INDUCED Agrancnocytosis
THE POSSIBLE ROLE OF LEUKOCYTE-GENERATED REACTrVE INTERMEDIATES IN THE DRUG-INDUCED AGRANCnOCYTOSIS Zhao Chao Liu A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Faculty of Pharmacy University of Toronto O Copyright by Zhao Chao Liu 1997 National Library Bibliothèque nationale (*m of Canada du Canada Acquisitions and Acquisitions et Bibliographic Services services bibliographiques 395 Wellington Street 395, rue Wellington Ottawa ON K1A ON4 Ottawa ON KIA ON4 Canada Canada The author has granted a non- L'auteur a accordé une licence non exclusive licence allowing the exclusive permettant a la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or seil reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la fome de microfiche/£ïlm, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fkom it Ni la thèse ni des extraits substantiels may be printed or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. ABSTRACT Ticlopidine and clczapine are associated with relatively high incidences of agranulocytosis. 5-aminosalicylic acid (5-ASA) is an agent widely used in the treatment of inflammatory bowel disease. It has been demonstrated that many drugs associated with drug-induced agranulocytosis or dmg-induced lupus are oxidized by activated neutrophils to reactive intermediates, by the combination of myeloperoxidase (MPO), hydrogen peroxide and chloride ion, or simply by hypochlorous acid (HOCI). -
And Radiation Therapy Sensitizing Strategies in Tumours with Focus on Effects of Phenothiazines on Dna Damage Response Signalling
From DEPARTMENT OF ONCOLOGY-PATHOLOGY Karolinska Institutet, Stockholm, Sweden ANALYSIS AND CHARACTERIZATION OF CHEMO- AND RADIATION THERAPY SENSITIZING STRATEGIES IN TUMOURS WITH FOCUS ON EFFECTS OF PHENOTHIAZINES ON DNA DAMAGE RESPONSE SIGNALLING Katarzyna Zielinska-Chomej Stockholm 2015 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-Print AB 2015 © Katarzyna Zielinska-Chomej, 2015 ISBN 978-91-7549-898-0 Analysis and characterization of chemo- and radiation therapy sensitizing strategies in tumours with focus on effects of phenothiazines on DNA damage response signalling THESIS FOR DOCTORAL DEGREE (Ph.D.) Dept of Oncology-Pathology, Cancer Center Karolinska (CCK) Lecture Hall, R8:00, Karolinska University Hospital, Stockholm Friday, the 16th of October, 2015, at 09:00 By Katarzyna Zielinska-Chomej Principal Supervisor: Opponent: Kristina Viktorsson, PhD Associate Prof Karin Roberg, MD, PhD Karolinska Institutet Linköping University Department of Oncology-Pathology Department of Clinical and Experimental Medicine Division of Otorhinolaryngology Co-supervisor(s): Petra Hååg, PhD Examination Board: Karolinska Institutet Associate Prof Marika Nestor, MD, PhD Department of Oncology-Pathology Uppsala University Department of Surgical Sciences, Otolaryngology and Head & Neck Surgery and Department of Professor Rolf Lewensohn, MD, PhD Immunology, Genetics and Pathology Karolinska Institutet Division of Biomedical Radiation Sciences Department of Oncology-Pathology -
Ethidium Bromide Use and Disposal
Ethidium Bromide Use and Disposal NOTE: Ethidium bromide is a chemical and should NOT be treated or labeled as a biohazard Ethidium Bromide (EtBr), commonly used in research laboratories as a stain for the visualization of nucleic acids in electrophoresis gels, is a toxic chemical and a potent mutagen. When used in nucleic acid staining, ethidium bromide fluoresces a red-orange to pink color under ultraviolet light and with increased fluorescence when bound to double-stranded DNA. While it is not specifically regulated as a hazardous waste, the mutagenic properties may present health hazards and disposal concerns if it is not managed properly in the laboratory. Required PPE: Always wear a lab coat, gloves, and appropriate protective eyewear when handling ethidium bromide and/or ethidium bromide containing material. Proper skin and eye protection are also needed when an ultraviolet (UV) light source is used while working with ethidium bromide. Avoid exposing unprotected skin and eyes to intense UV sources. A face shield is suggested if the UV source is pointing upwards. Guidelines for Ethidium Bromide Disposal: Stock Solutions: Stock solutions of ethidium bromide typically contain higher concentrations of ethidium bromide (approximately 10 mg/ml). Contact the Office of Environmental Safety & Services for collection and proper disposal of all unwanted stock solutions of ethidium bromide. Electrophoresis Gels and Buffers: Solid ethidium bromide waste (e.g., gels) typically contains 3 –5 ug/ml of ethidium bromide. Liquid ethidium bromide -
Come-Back of Phenanthridine and Phenanthridinium Derivatives in the 21St Century
Come-back of phenanthridine and phenanthridinium derivatives in the 21st century Lidija-Marija Tumir, Marijana Radić Stojković and Ivo Piantanida* Review Open Access Address: Beilstein J. Org. Chem. 2014, 10, 2930–2954. Laboratory for Study of Interactions of Biomacromolecules, Division of doi:10.3762/bjoc.10.312 Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Bijenička cesta 54, PO Box 180, HR-10002 Zagreb, Croatia Received: 17 July 2014 Accepted: 21 November 2014 Email: Published: 10 December 2014 Ivo Piantanida* - [email protected] This article is part of the Thematic Series "Nucleic acid chemistry". * Corresponding author Guest Editor: H.-A. Wagenknecht Keywords: ds-DNA and ds-RNA binding; intercalation; minor groove binding; © 2014 Tumir et al; licensee Beilstein-Institut. nucleic acids; organic synthesis; phenanthridine; phenanthridinium License and terms: see end of document. Abstract Phenanthridine derivatives are one of the most intensively studied families of biologically active compounds with efficient DNA binding capability. Attracting attention since DNA structure discovery (1960s), they were early recognized as a symbol of DNA intercalative binding, for many decades applied as gold-standard DNA- and RNA-fluorescent markers (ethidium bromide), probes for cell viability (propidium iodide), but also “ill-famed” for various toxic (genotoxic) and mutagenic effects. After two decades of low interest, the discovery of phenanthridine alkaloids and new studies of antiparasitic/antitumor properties of phenanthridine derivatives resulted in the strong increase of the scientific interest about the turn of this century. Here are summarized phenanthri- dine-related advances in the 21st century (2000-present period) with emphasis on the supramolecular interactions and bioorganic chemistry, as well as novel or improved synthetic approaches. -
Ethidium Bromide: Disposal, Decontamination, Procedure: 8.03 Created: 2/28/2012 and Destruction Version: 2.1 Revised: 1/27/2016
Ethidium Bromide: Disposal, Decontamination, Procedure: 8.03 Created: 2/28/2012 and Destruction Version: 2.1 Revised: 1/27/2016 A. Purpose 1. This policy provides general guidance to researchers and labs on how to work safely with Ethidium bromide. This mix has been designated as “particularly hazardous” by OSHA. This Policy will describe the minimum requirements for the safe storage, use, handling, and disposal of particularly hazardous substances, including spill and accident response procedures. 2. Ethidium bromide is mutagenic and moderately toxic and must be handled with care. The powder form is considered an irritant to the upper respiratory tract, eyes, and skin. Ethidium bromide is thought to act as a mutagen because it bonds in double stranded DNA, thereby deforming the molecule. This is believed to block or trip biological processes occurring on DNA. Preparation of stock solutions and any operations capable of generating Ethidium bromide dust or aerosols should be conducted in a fume hood to prevent inhalation. Nitrile gloves, a lab coat, and eye protection should be worn at all times, as with working with any hazardous material. B. Applicability/Scope 1. This Policy is applicable to, and must be adhered to by, all Columbia University laboratory workers (i.e., Principal Investigators, laboratory personnel, students, visiting researchers, etc.) who use or work with Ethidium bromide. Careful handling and stringent controls of Ethidium bromide is essential in order to protect workers and the environment, and to comply with OSHA regulations. 2. Additional safety requirements may apply, depending on if Ethidium bromide is mixed/used with a specific chemical.